What are BioMarin Pharmaceuticals's profit margins?

BioMarin Pharmaceuticals (BMRN) runs a 76.5% gross margin and a 19.9% operating margin, with a 16.8% net margin.

Where do BioMarin Pharmaceuticals's ratios come from?

Every ratio is computed from BioMarin Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

BioMarin Pharmaceuticals BMRN Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	76.5%-1.2pp	77.7%-3.6pp	81.3%+1.8pp	79.6%+0.1pp	79.4%-0.2pp
EBITDA margin	13.5%-3.2pp	16.7%-5.9pp	22.6%-5.5pp	28%+4.0pp	24.1%+3.7pp
Free cash flow margin	23.7%+1.2pp	22.5%-4.4pp	26.9%+4.2pp	22.7%+1.5pp	21.2%+4.1pp
Returns
Return on invested capital	5.2%-1.4pp	6.6%-2.1pp	8.8%-1.9pp	10.7%+2.2pp	8.5%+0.5pp
Efficiency
Asset turnover	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×
Inventory turnover	0.6×0.0×	0.6×+0.1×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Liquidity
Current ratio	5.8×+0.6×	5.2×+0.4×	4.8×-0.7×	5.6×0.0×	5.5×+0.2×
Quick ratio	4.2×+0.7×	3.5×+0.4×	3.1×-0.5×	3.6×+0.1×	3.5×+0.2×
Cash ratio	3.9×+2.1×	1.7×+0.2×	1.6×-0.2×	1.8×+0.1×	1.7×+0.1×
Leverage
Debt-to-equity	0.2×+0.1×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×+0.1×
Debt-to-assets	0.2×+0.1×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×+0.1×
Net debt / EBITDA	-3.8×-2.5×	-1.2×-0.3×	-0.9×-0.2×	-0.7×-0.1×	-0.6×+0.9×
Interest coverage	15.8×-26.1×	41.9×-15.6×	57.5×-12.5×	70×+18.3×	51.7×+13.5×
Per Share
Book value per share	$31.43+1.9%	$30.84-2.2%	$31.54+3.1%	$30.58+3.7%	$29.49+2.5%
Valuation
Market capitalization	$10.86B-4.8%	$11.42B+9.8%	$10.4B-0.8%	$10.49B-22.2%	$13.49B+7.7%
Enterprise value	$9.22B-14.2%	$10.75B+10.2%	$9.75B-1.3%	$9.87B-24.3%	$13.04B+12.2%
Price / sales	3.4×-0.2×	3.5×+0.2×	3.4×-0.1×	3.4×-1.1×	4.6×+0.2×
Price / book	1.7×-0.1×	1.9×+0.2×	1.7×0.0×	1.7×-0.6×	2.3×+0.1×
EV / EBITDA	21.1×+1.1×	20×+6.1×	14×+2.5×	11.5×-6.9×	18.3×-1.7×
EV / sales	2.8×-0.5×	3.3×+0.2×	3.2×-0.1×	3.2×-1.2×	4.4×+0.3×
Free cash flow yield	7.1%+0.7pp	6.3%-1.7pp	8%+1.4pp	6.6%+2.0pp	4.6%+0.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about BioMarin Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are BioMarin Pharmaceuticals's profit margins?: BioMarin Pharmaceuticals (BMRN) runs a 76.5% gross margin and a 19.9% operating margin, with a 16.8% net margin.
Where do BioMarin Pharmaceuticals's ratios come from?: Every ratio is computed from BioMarin Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.